Impact Biomedical Inc. SEC filings IBO
Impact Biomedical Inc. has 155 filings in SEC EDGAR's recent list, going back to Feb 12, 2021. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Oct 7, 2026 |
| 4 | Insider transaction | Sep 24, 2026 | Sep 22, 2026 |
| 144 | Notice of proposed sale | Apr 29, 2026 | — |
| 4 | Insider transaction | Mar 30, 2026 | Mar 25, 2026 |
| 4 | Insider transaction | Mar 25, 2026 | Mar 23, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | May 22, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 22, 2025 |
| 4 | Insider transaction | Apr 7, 2025 | Apr 4, 2025 |
| 4 | Insider transaction | Apr 7, 2025 | Apr 3, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Apr 2, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 4, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 2, 2025 | — |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 24, 2025 | Dec 2, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 5, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 26, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Sep 19, 2024 | Sep 18, 2024 |
| 4 | Insider transaction | Sep 18, 2024 | Sep 16, 2024 |
| 3/A | Filing | Sep 18, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 17, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
| 3 | Initial insider ownership | Sep 16, 2024 | Sep 16, 2024 |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IBO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- West Henrietta, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1834105
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.